Given the notorious lack of informed consent in the practice of psychiatry and a tendency to use typical consent forms to protect professionals rather than inform or empower patients, the authors propose a “model consent form” for psychiatric drug treatment. This form seeks to highlight the dubious nature of medical knowledge about psychological problems diagnosed and treated, to describe regulatory processes that result in truncated knowledge about prescribed drugs, and to present realistic and understandable information about somatic and psychological effects of drug use and drug withdrawal.
Get full access to this article
View all access options for this article.
References
1.
Cohen, D.
(1997). A critique of the use of neuroleptic drugs in psychiatry. In S. Fisher & S. Greenberg (Eds.), From placebo to panacea: Putting psychiatric drugs to the test (pp. 173-228). New York: Wiley.
2.
Jacobs, D. H.
(1995). Psychiatric drugging: Forty years of pseudo-science, self-interest, and indifference to harm. Journal of Mind and Behavior, 16, 421-470.
3.
McCubbin, M.
, & Cohen, D. (1996). Extremely unbalanced: Interest divergence and power disparity between clients and psychiatry. International Journal of Law and Psychiatry, 19, 1-25.
